Mutations of the RET gene, encoding a receptor tyrosine kinase, have been associated with the inherited cancer syndromes MEN 2A and MEN 2B. They have also further been associated with both familial and sporadic medullary thyroid carcinomas. Missense mutations aecting cysteine residues within the extracellular domain of the receptor causes constitutive tyrosine kinase activation through the formation of disul®de-bonded homodimers. We have recently reported that a somatic 6 bp in-frame deletion, originally coding for Glu632-Leu633, potently activates the RET gene. This activation is increased with respect to the frequent MEN 2A-associated missense mutation Cys634Arg. This ®nding speci®cally correlated to the clinic behavior of the corresponding tumor, which was characterized by an unusually aggressive progression with both multiple and recurrent metastases. By examining the possibility that this deletion acts in a manner similar to cysteine substitution, we have analysed the molecular mechanism by which this oncogenic activation occurs. Phosphorylated dimers of the deleted Ret receptor were detected in immunoprecipitates separated under non-reducing conditions. Like other Cys point mutations, this 6 bp deletion aecting two amino acid residues between two adjacent Cys, is capable of activating the transforming ability of Ret by promoting receptor dimerization. These results suggest that alteration to cysteine residue position or pairing is capable of inducing ligand independent dimerization. Furthermore, we present data demonstrating that the processing and sorting of the Ret membrane receptor to the cell surface is aected by mutation type.
Introduction
Medullary thyroid carcinoma (MTC) is a malignant tumor arising from calcitonin-secreting parafollicular C cells. MTCs may occur sporadically or as a component of the familial cancer syndrome known as multiple endocrine neoplasia type 2 (MEN 2A). Germline mutations within the RET proto-oncogene, coding for a receptor tyrosine kinase, can cause the MEN 2A, MEN 2B, and FMTC syndromes. The majority of germline mutations reportedly associated with MEN 2A and FMTC lie within exons 10 and 11 of RET. These mutations speci®cally occur at codons 609, 611, 618, 620 and 634 and universally result in the substitution of a cysteine residue (Mulligan et al., 1993; Donis-Keller et al., 1993) . A single point mutation at codon 918, causing the substitution of a methionine (ATG) with a threonine (ACG), is associated with both MEN 2B and sporadic MTC (Eng et al., , 1995b Carlson et al., 1994; Hofstra et al., 1994; Muragaki et al., 1995; Blaugrund et al., 1994) . Approximately 80% of sporadic MTCs are positive for this speci®c RET codon 918 mutation (Eng et al., 1995b (Eng et al., , 1996 . In contrast, two other relatively rare somatic mutations, at codons 768 (exon 13) and 883 (exon 15), are detected in approximately 10% of sporadic MTCs (Bolino et al., 1995; Eng et al., 1995a; Komminoth et al., 1995) . We have recently described two additional interstitial deletions aecting exons 10 and 11 (Romei et al., 1996; Ceccherini et al., 1997) . These novel somatic mutations, found in two dierent patients, were heterozygous in frame deletions of 48 (cod 592 ± 607) and 6 bp (cod 632 ± 633) respectively, yet did not directly involve any cysteine residues. Other similar codon deletions have been observed in sporadic MTCs, namely a 3 bp deletion (cod 633) (Hofstra et al., 1996) , and a 27 bp deletion comprising exon 10 ( Kalinin and Frilling, 1998) . Of interest, a duplication of 12 bp between codon Cys634 and Arg635, resulting in the insertion of four amino acids including a cysteine, has been described as a novel MEN 2A family germline mutation (Hoppner and Ritter, 1997) . It has been demonstrated that missense mutations involving any of the cysteine residues 609, 611, 618, 620 and 634, typical of the MEN 2A and FMTC phenotypes yet rarely identi®ed in sporadic MTCs, can promote ligand independent Ret dimerization leading to constitutive enzymatic activation. It is further evident that the substitution of one of these ®ve crucial cysteines leads to both ligand independent dimerization and receptor phosphorylation. We have recently demonstrated in an in vitro system that the deletion of the codons 632 ± 633 more eectively activated the RET gene with respect to the Cys634Arg missense mutation. This speci®cally correlated to the clinical severity of the corresponding tumor, characterized by an unusual aggressive progression with both multiple and recurrent metastases (Ceccherini et al., 1997) .
In this paper, we addressed the problem of the molecular mechanism underlying this oncogenic activation. We examined the possibility that these deletions act in a similar way to Cys point mutations. Phosphorylated dimers of the deleted Ret receptor are detected when immunoprecipitates are separated under non-reducing conditions. Therefore, like Cys point mutations, this deletion aecting two Cysproximal residues is capable of activating the transforming ability of Ret by promoting ligandindependent receptor dimerization.
Furthermore, we have studied the biogenesis of RetCys634Arg and Retdel1632 ± 633 and found that the latter to be more slowly processed to the cell surface. A large fraction of Retdel632 ± 633 intermediates and a signi®cantly smaller fraction of RetCys634Arg, is retained within the endoplasmic reticulum where it dimerizes and transduces mitogenic signals. To examine whether increased kinase activity correlated with increases in covalent dimer formation, we analysed immunoprecipitated RetD6, Ret2A and Retwt proteins by SDS ± PAGE under both reducing and non-reducing conditions. As shown in Figure 1A , Ret immunoprecipitates separated under non-reducing conditions revealed the presence of Ret dimers in cell lines expressing mutant receptors. Stable dimer formation was not detected in a cell line expressing the wild-type Ret receptor. Furthermore, RetD6 and Ret2A dimers were shown to be strongly phosphorylated ( Figure 1B ) by anti-phosphotyrosine immunoblotting. Two high molecular bands corresponding to the dimerized form of the mature (160 kDa) and the partially glycosylated precursor (140 kDa) of the mutated receptor, appeared phosphorylated. Duplicate immunoprecipitates were subjected to immunoblot analysis for Ret after separation under reducing conditions to determine whether receptor dimerization required disul®de bonding ( Figure 1C) . Results revealed that under reducing conditions, only monomeric forms of Ret were detected. These results provide evidence that the Ret Glu632-Leu633 deletion promotes disul®de-linked dimer formation. Ret proteins were further analysed under non-reducing conditions by 125 I-labeled protein-A binding (data not shown). Densitometric analysis of bands corresponding to dimers or monomers of the two mutant receptors revealed that RetD6 protein exhibits a greater ability to dimerize in comparison to Ret2A protein. The molar ratio of dimers to monomers for RetD6 and Ret2A was 0.95 and 0.70 respectively. In contrast, the Retwt control ratio was 0.05. Results from in vitro kinase assays, and from both reducing and non-reducing immunoblots demonstrated that the D6 deletion mutation is a gain-of-function mutation. This results in the constitutive activation of Ret, thus allowing for ligand-independent signal transduction. 
Results

Eect of
Eect of 2-mercaptoethanol treatment on Ret mutants transforming activity
Reducing agents have previously been used to interfere with the signaling from activated forms of both the thrombopoietin and NEU receptor (Alexander et al., 1995; Siegel and Muller, 1996) . We examined whether the addition of 2-mercaptoethanol (2-ME) could interfere with the ability of the RetD6 deletion mutant or the Ret2A point mutant to transform NIH3T3 cells. Addition of increasing concentrations of 2-ME (Table  1) failed to aect the transforming activity of the RetD6 construct. In contrast, Ret2A transforming activity decreased by 84% at the maximal dose (500 mM) of 2-ME. Toxic eects due to 2-ME at 500 mM were not evident as demonstrated by the unaected ability of RetD6 and HRAS in transforming NIH3T3 cells. This data demonstrates that RetD6 has a greater resistance to a reducing agent in comparison with Ret2A. This speci®cally correlates to a stronger disul®de bond formation in the RetD6 mutant.
Biosynthesis and glycan processing of RetD6 and Ret2A proteins and eects of 2-mercaptoethanol treatment
It has previously been demonstrated that proteins exposing reactive thiols are often retained within the endoplasmic reticulum (ER) (Isidoro et al., 1996) . This protein quality control system has been termed thiolmediated retention. This mechanism is believed to monitor the oxidation status of one or more cysteines contained in protein sequences. Since RetD6 and Ret2A mutations aect critical cysteine residues, we studied both the biosynthesis and relative kinetics of dimerization by following the fate of metabolically labeled mutant receptors in NIH3T3 cells. Subcon¯uent cultures were labeled with 0.35 mCi/ml 35 Smethionine-cysteine for 15 min and subsequently chased for varying times. Under reducing conditions, newly synthesized protein for both mutant receptors appeared in the 140 kDa form immediately after the pulse (Figure 2 ). The amount of Ret2A p140 protein increased signi®cantly within the ®rst hour of chase and gradually decreased after 2 h. The mature p160 form appeared after 1 h of chase. In contrast, RetD6 p140 reached a maximum intensity only after 2 h of chase, the same chase time at which the mature p160 form became evident. Since the 140 kDa is the endoglycosidase H sensitive form (data not shown and (Asai et al., 1995) ) whilst the 160 kDa is resistant, we deduced the longer persistence of the RetD6 140 kDa precursor. This indicated that RetD6 has a less ecient ER processing compared to the Ret2A precursor. The amount of the mature 160 kDa Ret2A protein was similar to that of the precursor after 2 h of chase, with a maximum reached after 4 h. In contrast, the amount of the 160 kDa RetD6 protein increased slowly, yet always remained less than the 140 kDa form. To explore the mechanism of dimerization, features of the labeled RetD6 and Ret2A proteins were also followed as a function of time by nonreducing SDS ± PAGE (Figure 2 ). Both the precursor and mature forms of RetD6 and Ret2A were capable of dimerization, each with individual speci®c kinetics (Figure 2) . The formation of RetD6 homodimers in both the p140 and p160 forms was observed from 2 h. In contrast, after 1 h of chase in the Ret2A mutant, a consistent amount of p140 homodimers and only a small fraction of p160 homodimers were observed. Furthermore, p160 homodimers were observed almost exclusively after longer chase times. Analysis of phosphorylation levels in all RetD6 and Ret2A proteins indicated that most of the precursors were signi®cantly phosphorylated, irrespective of whether in the monomeric or dimeric form ( Figures 3B and 1B and data not shown). This is due to the fact that phosphorylation associated to dimer forms is intermolecular. Therefore, SDS ± PAGE under reducing conditions produces phosphorylated monomers.
Co-immunoprecipitation of SHC phosphorylated proteins with both the precursor and mature forms of the RetD6 and Ret2A receptors RetD6 proteins are characterized by slower maturation kinetics yet display stronger oncogenic activity in comparison to Ret2A proteins. With the aim to explain this fact, we speculated that both the p140 precursor and p160 mature forms of Ret, when Focus assays were performed with 125 ng of plasmid per plate in the presence of increasing concentrations of 2-ME. Foci were scored over six plates for each concentration after 3 weeks. The HRAS oncogene mutated at its 12th codon was used as a control. Values listed represent the average+s.d. of the number of foci counted on six plates Figure 2 Pulse-chase labeling of RetD6 and Ret2A proteins in reducing and non-reducing conditions. Autoradiograms of metabolically labeled radioactive RetD6 and Ret2A proteins derived from transfectants pulsed for 15 min and harvested immediately (lanes marked 0) or after the indicated chase time (lanes marked 1 ± 6). Cell extracts were immunoprecipitated with anti-Ret antiserum and the complexes were separated by SDS ± PAGE under either reducing or non-reducing conditions. Gels were exposed to X-ray ®lm for 4 ± 5 days. Numbers are molecular weights in kDa phosphorylated and dimerized, are able to transduce mitogenic activity in spite of their dierent localization; the endoplasmic reticulum or surface membrane respectively. To address this, we investigated whether the precursor forms of RetD6 and Ret2A were able to bind the Shc adapter protein. This protein is localized to the membrane of the rough endoplasmic reticulum and has been previously demonstrated to bind Ret/ PTCs, Ret2A and Ret2B (a mutant Ret receptor carrying an M918T mutation) oncoproteins (Lotti et al., 1996) . Cell lysates from RetD6 and Ret2A transfected NIH3T3 cells were immunoprecipitated with anti-Shc or anti-Ret antibodies and subsequently blotted with anti-Ptyr antibodies (Figure 3 ). Both the precursor and mature forms of Ret were coimmunoprecipitated with Shc phosphorylated proteins. The band density of both RetD6 and Ret2A co-immunoprecipitated or not with Shc protein and probed with anti-Ptyr were checked by densitometric analysis. The observed anity of Shc for the precursor and mature forms of both the mutated receptors is similar. Considering the sum of the relative amounts, it was calculated that 40% of RetD6 and 20% of Ret2A were co-immunoprecipitated with Shc phosphorylated proteins. It is thus possible to conclude from this data that the mitogenic signal transduced by Shc does not depend on maturation or localization of the mutated receptor, but possibly in¯uenced by the speci®c type of activating mutation.
Discussion
We have demonstrated that deletion of the residues Glu632-Leu633 of Ret induces stable receptor dimer formation in the absence of ligand. This suggests that constitutive dimerization and autophosphorylation of the receptor protein underlies the potent transforming activity of this Ret mutant. MEN 2A mutations destroy Cys residues, thus indicating that their mechanism of action involves the creation of ligandindependent dimers most likely through aberrant intermolecular disul®de-bond formation. Whilst not directly involving Cys residues, the D6 mutation also induces such dimerization. This deletion mutation may indirectly aect neighboring Cys residues by disrupting the normal and most likely intramolecular cysteine pairing, which occurs in the non-activated receptor. This thus leaves the possibility that at least one unpaired cysteine residue may participate in an intermolecular binding event with another altered receptor, resulting in a disul®de-bonded receptor dimer leading to aberrant receptor activation. In fact, a similar mechanism has been proposed to account for the oncogenic activation in Neu deletion mutants. Deletion of conserved cysteine residues in the juxtatransmembrane region of Neu resulted in elevated transforming activities compared to that of the C647S point mutation form (Siege and Muller, 1996) . One potential explanation for this observation is that the spatial arrangement between the remaining cysteine residues may play a crucial role in mediating receptor dimerization. For example, certain deletions may result in a free cysteine being exposed at the surface of the receptor, thus making it more accessible to intermolecular disul®de bond formation.
Interestingly, the transforming activity of Ret2A receptor is decreased following the addition of a reducing agent. In contrast, the transforming activity of the RetD6 deletion mutant is not signi®cantly impaired at the same non toxic concentration of 2-ME. This may be explained by the formation of more stable RetD6 disul®de-linked dimers, thus generating a more ecient covalent dimerization. Alternatively, it is possible that the loss of residues near cysteine 634 results in an unfolding of the cysteine rich domain that may lead to a less compact and more¯exible conformation. Such an unfolding could increase the probability of receptor interaction on the plasma membrane, leading to the tyrosine kinase activation C and D) antiserum. The resulting complexes were electrophoresed on a 7.5% SDS ± PAGE under reducing conditions. Proteins were transferred to nitrocellulose and subjected to immunoblot analysis (BLOT) with anti-phosphotyrosine (aPtyr) or antiRet (aRet) antiserum. RetD6 and Ret2A expressing cell lines were serum starved for 48 h. Numbers are molecular weights in kDa and correspond to two of the three dierent isoforms of Shc (p52 and p46) and to Ret (p160 and p140), respectively of a greater number of mutant receptors compared to the Ret2A type receptor. Finally, the lower sensitivity of the D6 mutant to reducing agents could also be explained by its particular molecular equilibrium shift from monomeric to dimeric/oligomeric forms.
Taken together, these observations suggest that both the number and spatial arrangement of cysteine residues may induce a ligand independent dimerization. More generally, it is possible that the loss, gain or mutation or residues within the cysteine-rich region of Ret has the capacity to induce stabilization of the dimeric conformation through intermolecular disul®de bonds.
Biosynthesis studies of RetD6 and Ret2A proteins have shown a slower rate of maturation for RetD6 protein due to precursor retention in the endoplasmic reticulum. However, both RetD6 and Ret2A show intracellular retention in comparison with the Retwt protein, which reaches the membrane within a 30 min chase time (data not shown). This is expected since, as a rule, only proteins that have attained a proper threedimensional structure are secreted or expressed at the cell surface. Since RetD6 and Ret2A are mutated near or within Cys, their folding and assembly could potentially be delayed by intracellular retention for a longer time with respect to Retwt.
Accumulation of misfolded immature Ret2A and RetD6 proteins in the intracellular vesicular compartment and its homodimerization due to aberrant intermolecular disul®de bonds have important consequences on receptor functions in the downstream mitogenic program. In fact, a very large portion of RetD6 and Ret2A precursors strongly bind phosphorylated Shc proteins, thus indicating their ability to induce this mitogenic signal pathway. This ®nding may also aid in explaining why the RetD6 protein is more oncogenic, even when less eciently processed than Ret2A mutant; an obvious paradox. The possibility that intracellular Ret precursors still trigger a mitogenic activity is extremely important also in the context of the eects of cysteine mutation in positions 609, 618 and 620. There is evidence suggesting that these cysteine mutations induce constitutive catalytic activity due to aberrant disul®de homodimerization of Ret, but in the same time are responsible for a decrease in the amount of mature RET protein expressed at the cell surface (Chappuis-Flament et al., 1998) . Since 20 ± 30% of families with mutations C618R or C620R ) present a combination of HSRC and MEN 2A, it has been hypothesized that these cysteine mutations exert a dual impact on RET. In particular, these mutations can be activating or deactivating depending on the tissue in which RET is expressed. Thus, RET carrying either the C618R or C620R mutation, due to constitutive dimerization, exhibits a transforming potential responsible for MEN2A and in the same time, due to scarce localization at the surface membrane, an inability to promote a survival of enteric neurons. Our data well supports this model, indicating that not exclusively the membrane can trigger mitogenic signals. This reinforces the concept that an ecient membrane localization of Ret receptors is very important for triggering of neuronal dierentiation signals.
Materials and methods
Cell culture and transfection
Mouse NIH3T3 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% calf serum. Transfection experiments were performed in NIH3T3 cells by calcium phosphate precipitation as previously described (Bongarzone et al., 1993) . Plasmids carrying Retwt, RetD6 and Ret2A inserts have been described in detail previously (Ceccherini et al., 1997) . The HRAS oncogene was mutated at its 12th codon by a G?T transversion. Transformation foci were selected in DMEM plus 5% calf serum. The reducing agent 2-ME was added when cells had formed a monolayer. This monolayer was maintained for 14 days in DMEM supplemented with 5% bovine calf serum.
Immunoprecipitation and Western blot analysis
Protein samples were prepared as previously described (Borrello et al., 1996) and immunoprecipitated with the speci®ed antisera: anity puri®ed anti-Ret polyclonal antiserum (Borrello et al., 1996) and rabbit polyclonal antiShc antiserum (Upstate Biotechnology Incorporated). Immunoprecipitates were resolved by electrophoresis on 7.5 or 8.5% SDS polyacrylamide gels (PAGE). Proteins were transferred to nitrocellulose ®lters, blocked with 5% bovine serum albumin (BSA) or 0.5% gelatin in Tris-buered saline (TBS) pH 7.6 and immunoblotted with the same anti-Ret antiserum described above or with the monoclonal antiserum anti-phosphotyrosine (anti-Ptyr, Upstate Biotechnology Incorporated). Immunoreactive bands were visualized using horseradish peroxidase conjugated anti-rabbit or anti-mouse antisera and ECL detection reagents (Amersham) or using 125 I-labeled protein A (Amersham) followed by autoradiography. When 125 I-labeled protein A was used, ®lters were exposed to storage phosphor screen ®lms (Molecular Dynamics) in order to quantify the counts per minute (c.p.m.) associated with the Ret-speci®c bands reacting with anti-Ret or anti-Shc with a Phosphorimager. For Western blotting under non-reducing conditions, 2-mercaptoethanol was excluded.
Metabolic labeling and immunoprecipitation
Prior to labeling, subcon¯uent cells were incubated with methionine-free DMEM for 1 h. Metabolically labeling was performed with 370 mCi/mL 35 S-Methionine-Cysteine (DuPont/NEN) for 15 min. The labeling medium was then removed and replaced with completed DMEM medium for the duration of the chase period. Further processing, extraction, and immunoprecipitation of labeled Ret was carried out as above with the following modi®cations: after incubation, bound immune complexes (Protein A/G-PlusAgarose beads, Santa Cruz Biotechnology) were washed extensively (seven times) with lysis buer (0.15 mM NaCl/ 0.05 mM Tris-HCl, pH 7.2/1% Triton X-100/1% sodium deoxycholate/0.1% SDS), either supplemented with or without 1% Triton and 1 M NaCl and on a shaking platform, eluted, and subjected to SDS ± PAGE fractionation and autoradiography. Densities of radioactive bands on Xray ®lms were estimated using a Phosphorimager.
